Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
Related press release
Associated GWPRF transcripts
GWPRF similar filings
Filing view
External links
Exhibit 16.1
November 28, 2018
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561
Dear Sirs/Madams:
We have read Item 9 of GW Pharmaceuticals plc’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on November 28, 2018, and we agree with the statements made therein.
Yours truly,
/s/ Deloitte LLP
London, United Kingdom
AMECURRENT 730651623.1 27-Nov-18 15:34